Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents With Anxiety and Depression
Recruiting
N/A
Interventional Study
Anxiety and Depression
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 12 – 17
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 228 (estimated)
- Sponsor
- University of Calgary · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a parallel arm randomized (1:1) controlled trial. Adolescents aged 12-17 years (n=228) who are starting or changing a selective serotonin reuptake inhibitor (SSRI) for depression and/or anxiety will be randomly allocated to receive 12-weeks of pharmacogenetic-guided antidepressant therapy (experimental intervention) or current prescribing guidelines/recommendations guided therapy (control …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 12-17
* Depression and/or anxiety as the primary concern, confirmed by the treating physician
* Intention to start a new SSRI
* English fluency
Exclusion Criteria:
* Co-occurring obsessive compulsive disorder, psychosis, bipolar disorder, eating disorder, autism spectrum…
Contacts